Brandon’s Story: Metabolic dysfunction-associated steatotic liver disease with mild hepatomegaly and fibrosis risk
A 46-year-old regional sales director looking for an explanation for persistent fullness below the right ribs, fatigue, gradual weight gain, and no jaundice, fever, or severe pain
Brandon was a regional sales director whose first explanation was that post-meal gas was the only cause.
The decision changed when the fullness persisted and routine testing showed metabolic liver risk. The combination of persistent fullness below the right ribs, fatigue, gradual weight gain, and no jaundice, fever, or severe pain required a more specific evaluation.
Ultrasound confirmed diffuse steatosis and mild enlargement without a focal mass or bile-duct dilation. Metabolic risk, laboratory review, FIB-4, and elastography supported MASLD and separated liver fat from fibrosis severity.
The final plan used individualized nutrition, physical activity, gradual weight and metabolic-risk management, alcohol review, fibrosis-based follow-up, and evaluation of other causes of RUQ symptoms if fullness persisted. Follow-up measured safety, symptom resolution, objective recovery, and the risk of recurrence.
The ultrasound confirmed fat and size, but the fibrosis assessment told us what mattered for long-term risk.